Legislation – The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020
Changes to legislation:
There are currently no known outstanding effects for The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020, Section 18.
Changes to Legislation
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Amendment of regulation 28018.
“(4)
A person may not publish an advertisement for a medicinal product in relation to which there is in force an authorisation by the licensing authority on a temporary basis under regulation 174 (but not an authorisation, certificate or registration as mentioned in regulation 279(a) or (b) to (d)), unless it is published as part of a campaign that has been approved by the Ministers.”.